Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)

Phase 1

Recruiting

• Conditions: novel coronavirus pneumonia (COVID-19)

• Registration Number: ITMCTR2000002940
• Lead Sponsor: China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Comply with the diagnostic criteria for pneumonia caused by novel coronavirus infection in the Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 4);
2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.

Exclusion Criteria

1) Patients with particularly severe pneumonia caused by novel coronavirus infection.
2) Patients whose initial onset time exceeds 5 days.
3) Patients with severe primary respiratory disease.
4) It is difficult to administer to patients by oral or nasal feeding.
5) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the rate of remission;

Secondary Outcome Measures

Name	Time	Method
Blood biochemical test;Body temperature;the rate of disisolation;the rate of critcal aggravation;blood routine test;Blood oxygen saturation;TCM symptom score;Chest imaging;